MODIFICATION TO STANDARD HUMAN PLASMA

• K Number: K023141
• Device Name: MODIFICATION TO STANDARD HUMAN PLASMA
• Manufacturer: DADE BEHRING, INC.
• Date Cleared: 2003-01-16 ( 118 days)
• Product Code: JPA
• Regulation Number: 864.5425

Intended Use

For the calibration of the following tests: Prothrombin time (PT), Fibrinogen, Coagulation factors II, V, VII, VIII, VWF, IX, X, XI, XII and XIII*, Inhibitors: Antithrombin III, Protein C, Protein S, α2-antiplasmin, C1-inhibitor*, Total complement activity*, Plasminogen. (* Not available in the U.S.)

Device Description

Standard Human Plasma is a lyophilized calibrator prepared from pooled citrated human plasma, stabilized with buffer solution and then lyophilized. It is assayed for the calibration of various coagulation and fibrinolysis tests

Predicate Devices

K924393

Reference Devices

Not Found

AI/ML (Artificial Intelligence / Machine Learning)

No
The device description and performance studies focus on the stability and calibration properties of a plasma-based calibrator, with no mention of AI or ML technologies.

Therapeutic

No
This device is a calibrator used for in-vitro diagnostic tests, specifically for calibrating coagulation and fibrinolysis assays. It does not directly provide therapy to a patient.

Diagnostic

No
Explanation: This device is described as a "calibrator" used for the calibration of various coagulation and fibrinolysis tests, not as a diagnostic device itself. It helps ensure the accuracy of diagnostic tests by providing a reference standard.

SaMD (Software as a Medical Device)

No

The device description clearly states it is a lyophilized calibrator prepared from pooled human plasma, indicating it is a physical substance, not software.

IVD (In Vitro Diagnostic)

Yes, this device is an IVD (In Vitro Diagnostic).

Here's why:

• Intended Use: The intended use clearly states it is "For the calibration of the following tests: Prothrombin time (PT), Fibrinogen, Coagulation factors..." These are all tests performed in vitro (outside the body) on biological samples (plasma) to diagnose or monitor medical conditions related to coagulation and fibrinolysis.
• Device Description: The description states it is a "lyophilized calibrator prepared from pooled citrated human plasma... It is assayed for the calibration of various coagulation and fibrinolysis tests." Calibrators are essential components used in IVD tests to ensure accurate and reliable results.
• Predicate Device: The mention of a predicate device (K924393; Standard Human Plasma) further supports its classification as an IVD, as predicate devices are used to demonstrate substantial equivalence for new IVD submissions to regulatory bodies like the FDA.

The information provided aligns perfectly with the definition and characteristics of an In Vitro Diagnostic device.

PCCP (Predetermined Change Control Plan) Authorized

N/A

Overview

Intended Use / Indications for Use

For the calibration of the following tests:

• 1. Prothrombin time (PT)
• 2. Fibrinogen
• 3. Coagulation factors II, V, VII, VIII, WWf, IX, X, XI, XII and XIII*
• 4. Inhibitors: Antithrombin III, Protein C, Protein S, a2-antiplasmin, C1-inhibitor*
• 5. Total complement activity*
• 6. Plasminogen

• Not available in the U.S.

Product codes

JPA

Device Description

Standard Human Plasma is a lyophilized calibrator prepared from pooled citrated human plasma, stabilized with buffer solution and then lyophilized. It is assayed for the calibration of various coagulation and fibrinolysis tests

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

Stability: In duplicate determinations, reconstituted stability data met the acceptance criteria of recovering within the assigned values for the following claims: 4 hours at +15 to +25°C, 4 weeks at -20 to -30°C (2 hours after thawing at +15 to +25°C, stored for 4 weeks at -20 to -30°C.)

Key Metrics

Not Found

Predicate Device(s)

K924393

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

Regulation Number and Section

§ 864.5425 Multipurpose system for in vitro coagulation studies.

(a)
Identification. A multipurpose system for in vitro coagulation studies is a device consisting of one automated or semiautomated instrument and its associated reagents and controls. The system is used to perform a series of coagulation studies and coagulation factor assays.(b)
Classification. Class II (special controls). A control intended for use with a multipurpose system for in vitro coagulation studies is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9.

Summary

0

K023141

JAN 1 6 2003

510(k) Summary Standard Human Plasma

• Manufacturer's Name, Address, Telephone, and Contact Person, Date of 1. Preparation:
  Manufacturer:

Dade Behring Marburg GmbH Emil-von-Behring Str. 76 Marburg/Germany

Contact Information:

Dade Behring Inc. Glasgow Site P.O. Box 6101 Newark, Delaware 19714 Attn: Donna Wolf Tel: [phone] September 19, 2002

Preparation date:

2. Device Name/ Classification:

Standard Human Plasma / Multipurpose system for in vitro coagulation studies (864.5425)

3. Identification of the Legally Marketed Device:

Standard Human Plasma (K924393)

4. Device Description:

Standard Human Plasma is a lyophilized calibrator prepared from pooled citrated human plasma, stabilized with buffer solution and then lyophilized. It is assayed for the calibration of various coagulation and fibrinolysis tests

5. Device Intended Use:

For the calibration of the following tests: Prothrombin time (PT), Fibrinogen, Coagulation factors II, V, VII, VIII, VWF, IX, X, XI, XII and XIII*, Inhibitors: Antithrombin III, Protein C, Protein S, α2-antiplasmin, C1-inhibitor*, Total complement activity*, Plasminogen. (* Not available in the U.S.)

6. Medical device to which equivalence is claimed and comparison information:

Standard Human Plasma (modified) is substantially equivalent in intended use to the Standard Human Plasma (K924393) currently marketed. Standard Human Plasma (modified), like the current Standard Human Plasma is intended for the calibration of coagulation and fibrinolysis tests using a variety of mechanical and photo-optical coagulation systems.

7. Device Performance Characteristics:

Stability:

In duplicate determinations, reconstituted stability data met the acceptance criteria of recovering within the assigned values for the following claims: 4 hours at +15 to +25°C, 4 weeks at -20 to -30°C (2 hours after thawing at +15 to +25°C, stored for 4 weeks at -20 to -30°C.)

1

Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, with flowing lines representing hair or clothing.

Food and Drug Administration 2098 Gaither Road Rockville MD 20850

Ms. Donna Wolf Senior Regulatory Affairs Specialist Dade Behring, Inc. Glasgow Site P.O. Box 6101 Newark, Delaware 19714

JAN 1 6 2003

Re: K023141

Trade/Device Name: Standard Human Plasma Regulation Number: 21 CFR § 864.5425 Regulation Name: Multipurpose system for in vitro coagulation studies Regulatory Class: II Product Code: JPA Dated: December 17, 2002 Received: December 18, 2002

Dear Ms. Wolf:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices. good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

2

Page 2 -

If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.

Sincerely yours,

Steven Sutman

Steven I. Gutman, M.D., M.B.A. Director Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health

Enclosure

3

Dade Behring Inc. Standard Human Plasma 510(k) Modification

Indications for Use Statement

Device Name: Standard Human Plasma

Indications for Use:

For the calibration of the following tests:

• 1. Prothrombin time (PT)
• 2. Fibrinogen
• 3. Coagulation factors II, V, VII, VIII, WWf, IX, X, XI, XII and XIII*
• 4. Inhibitors: Antithrombin III, Protein C, Protein S, a2-antiplasmin, C1-inhibitor*
• 5. Total complement activity*
• 6. Plasminogen

• Not available in the U.S.

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

Over-The-Counter-Use (Optional Format 1-2-96)

Auriphene Bautista

(Division Sign-Off) Division of Clinical Laborator 510(k) Number